Person

Back to overview Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Effect and mechanism of action of glial cell line derived neuro- trophic factor and neurturin on the dopaminergic nigro striatal system
Aebischer Patrick University of Lausanne - LA 01.10.1997 30.09.2000 Project funding (Div. I-III)

Spinal root regeneration using biosynthetic bridges; role of Schwann cells, trophic factors and extracellular matrix molecules
Aebischer Patrick University of Lausanne - LA 01.10.1993 30.09.1996 Project funding (Div. I-III)

Immunology of encapsulated cell transplantation using erythropoietin secreting cells
Aebischer Patrick University of Lausanne - LA 01.07.2000 30.06.2005 NRP 46 Implants and Transplants

Development of biotherapeutics based on lentiviral-mediated models of Parkinson's disease
Aebischer Patrick EPF Lausanne - EPFL 01.04.2005 31.03.2008 Project funding (Div. I-III)

Lentiviruses as vectors for the understanding and treatment of Parkinson's disease
Aebischer Patrick University of Lausanne - LA 01.04.2001 30.09.2004 Project funding (Div. I-III)

Development of a gene therapy approach for patients suffering from amyotrophic lateral sclerosis
Aebischer Patrick University of Lausanne - LA 01.03.1996 28.02.2001 NRP 37 Somatic Gene Therapy

From knowledge base of the pathogenic astrocyte-motoneuron communication in amyotrophic lateral sclerosis to therapeutic approaches
Aebischer Patrick EPF Lausanne - EPFL 01.02.2015 30.11.2018 Project funding (Div. I-III)

Common Pathogenic Pathways and Therapeutics for SMA and ALS motoneuron diseases (FaSMALS)
Aebischer Patrick EPF Lausanne - EPFL 01.02.2015 31.01.2018 ERA-NET

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Neurodegenerative Diseases: Animal Models and Clinical Applications "Réunion scientifique"
Kato Ann University of Geneva - GE 01.03.1996 31.08.1996 Scientific Conferences

Locomotion in paraplegic patients
Dietz Volker University of Zurich - ZH 01.05.1995 29.02.1996 Swiss Priority Programmes (SPPs)

Implantation stéréotaxique robotisée de capsules de cellules vivantes dans le cerveau humain
Glauser Dominique EPF Lausanne - EPFL 01.04.1994 30.04.1996 Project funding (Div. I-III)

Development and preclinical assessment of a bioartificial pancreas
Thorens Bernard University of Lausanne - LA 01.01.2001 31.12.2003 NRP 46 Implants and Transplants

Therapeutic approaches for HD in gentic models based on lenti- viral-mediated delivery of mutant huntingtin
Déglon Nicole University of Lausanne - LA 01.10.2001 30.09.2004 Project funding (Div. I-III)

Molecular, cellular and clinical aspects of neurodegenerative diseases (Workshop)
Kato Ann University of Geneva - GE 01.02.1995 31.07.1995 Scientific Conferences

Evaluation of lentiviral vectors expressing neurotrophic factors and anti-apoptotic proteins in rodent models of Huntington's disease
Déglon Nicole University of Lausanne - LA 01.10.1998 30.09.2001 Project funding (Div. I-III)

Neorotrophic factor therapy for motoneuron diseases
Zurn Anne University of Lausanne - LA 01.10.1995 30.09.1998 Project funding (Div. I-III)

Gene therapy approaches to atherosclerosis using second-gene- ration adenovirus gene transfer vectors
Vassalli Giuseppe University of Lausanne - LA 01.09.1998 31.08.2002 Project funding (Div. I-III)

Biofunctional gels for peripheral nerve regeneration
Hubbell Jeffrey Alan ETH Zurich - ETHZ 01.06.1998 30.06.2001 NRP 38 Diseases of the Nervous System

Neuroprotection in experimental models of amyotrophic lateral sclerosis and Parkinson's disease
Zurn Anne University of Lausanne - LA 01.10.1998 31.12.2001 Project funding (Div. I-III)

Motoneurons, neurotrophic factors and the treatment of ALS
Kato Ann University of Geneva - GE 01.01.1994 30.06.1994 Scientific Conferences

Molecular, cellular and clinical aspects of neurodegenerative diseases
Kato Ann University of Geneva - GE 01.07.1998 31.12.1998 Scientific Conferences

Neurodegenerative Diseases: Apoptotic and necrotic neuronal cell death (Workshop)
Kato Ann University of Geneva - GE 01.01.1997 30.06.1997 Scientific Conferences

Xenotransplantation: An Ethical Evaluation Giving Special Consideration to Animal Ethical Aspects
Arz de Falco Andrea University of Fribourg - FR 01.08.2000 31.08.2003 NRP 46 Implants and Transplants

Neuroprotection in experimental models of amyotrophic lateral sclerosis: pharmacological and gene therapy approaches
Zurn Anne University of Lausanne - LA 01.01.2002 31.03.2005 Project funding (Div. I-III)

-